Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
Farshad Nassiri(University Health Network), Daniel D. De Carvalho(University Health Network), Craig Horbinski(Northwestern University), Mathew Voisin(University Health Network), Romina Nejad(University Health Network), Ankur Chakravarthy(Princess Margaret Cancer Centre), Shu Yi Shen(University Health Network), Kenneth Aldape(National Institutes of Health), Shengrui Feng(University Health Network), Gelareh Zadeh(University Health Network), Vikas Patil(University Health Network), Jeffrey Zuccato(University of Oklahoma)
Cited by 270
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965